ÂÜÀòÂÒÂ×

Brad Raudabaugh serves as the Vice President of Product Strategy at Axsome Therapeutics, Inc., focusing on commercial go-to-market strategies for rare disease neuroscience and psychiatry. With a history of leadership roles at Axsome, including Vice President and Head of US Sales, Brad successfully established the sales force for psychiatric and sleep disorder therapies. Prior to Axsome, Brad held executive positions at Insmed Incorporated, Amgen, Teva Pharmaceuticals, and AstraZeneca, where Brad developed marketing strategies for various products, including ARIKAYCE and AIMOVIG. Brad holds an MBA from Washington University in St. Louis and a BA from Louisiana State University, specializing in English and Biology.